List of pharmaceutical compound number prefixes
This list of pharmaceutical compound number prefixes details a pharmaceutical drug labeling standard. Pharmaceutical companies produce a large number of compounds, which cannot all be given names. Instead, they are systematically numbered for internal reference. The number is prefixed with a letter code indicating which company synthesized the compound. For example, CP-529414 is the compound number for the recently failed Pfizer experimental drug torcetrapib. If the company or its agents choose to publish information or research results about the drug before it has been assigned a generic name (such as an INN, USAN, or BAN), they will refer to it by this number.
A large list of code designations with corresponding trade names can be found in Appendix IV of the USP Dictionary.
There are three primary methods of prefixing the numeric identifier - with a space,[1] with nothing,[2][3] and most commonly with a dash.[4]
A to F
- A – Abbott Laboratories now AbbVie [5]
- ABT - Abbott Laboratories now AbbVie [5]
- ABBV - AbbVie - [4]
- ACP - Acadia Phamarceuticals
- ACZ - Novartis
- ADL - Adolor Corporation[6]
- AG - Agouron, now Pfizer La Jolla Labs
- AH - Amersham plc (Amersham Health)
- AHR - A.H. Robins
- ALS - Alantos Pharmaceuticals, acquired by Amgen in June 2007
- ANX - Adventrx Pharmaceuticals[7]
- AMG - Amgen[8]
- ARQ - ArQule [1]
- ATL - Antisense Therapeutics Limited, Australia[9]
- AY - Ayerst, later Wyeth-Ayerst, ultimately acquired by Pfizer
- AZD - AstraZeneca
- Bay - Bayer AG
- BCX - Laboratoires Biocodex
- BIIB - Biogen
- BMS - Bristol-Myers Squibb
- BMY - Bristol-Myers Co., merging in 1989 into Bristol-Myers Squibb
- BRL - Beecham Research Labs, merged with SmithKline into SmithKline Beecham which merged into GlaxoSmithKline
- BTC - The Boots Company plc
- C - Laboratoires Cassenne
- CAS - Cassella Farbwerke Mainkur Aktiengesellschaft, later Hoechst, later Sanofi
- CAT - Cannasat Therapeutics Inc.
- CC - Celgene
- CE - Pfizer
- CGS - Ciba Geigy
- CP - Pfizer Groton. CP probably refers to the founder of the company, Charles Pfizer.
- CSL - CSL Limited, an Australian Biophamaceutical company
- CVX - CovX, acquired by Pfizer in 2008
- CYT - Cytopia of Australia, acquired by YM biosciences, subsequently by Gilead [10]
- DMP - DuPont Merck Pharmaceuticals, a joint venture between DuPont and Merck; became DuPont Pharmaceuticals in 1998
- DPC - DuPont Pharmaceuticals, acquired by Bristol-Myers Squibb in 2001
- DX - Dyax
- EAG - Eagle Pharmacy, a United States pharmaceutical compounding company [11]
- EMD - Merck KGaA (E. Merck), Darmstadt, Germany (refers to laboratory founder Emanuel Merck)
- ETC - Esperion Therapeutics, acquired by Pfizer in 2003, independent again since 2008
- F - Forest Labs, acquired by Actavis
- FCE - Farmitalia-Carlo Erba, later Pharmacia AB, later Pharmacia & Upjohn, acquired by Pfizer
- FK - Fermentek
G to L
- G - J. R. Geigy AG, ultimately merged into Novartis
- G - Genta Inc.
- GDC - Genentech Likely Genentech Development Candidate [12][13]
- GEH - GE Healthcare
- GNE - Genentech internal reference number, company pipeline uses GDC- prefixes [12] [14]
- GP - Geigy, merged with CIBA in 1971 to become Ciba‑Geigy, now Novartis
- GR - GlaxoSmithKline
- GS - Gilead Sciences
- GSK - GlaxoSmithKline
- HCV - ViroPharma
- ICI - Imperial Chemical Industries, acquired by AkzoNobel
- IDN - Idun pharmaceuticals, acquired by Pfizer
- ILY - Ilypsa, acquired by Amgen in 2007
- INNO - CytRx, a biotech company based in Los Angeles
- ISIS - Isis Pharmaceuticals (renamed Ionis Pharmaceuticals in 2015)
- JNJ - Johnson & Johnson
- KOS - Kosan Biosciences
- KW - Kyowa Hakko
- L - Labaz Group, acquired by Elf Aquitaine in 1973 to form Sanofi
- LU - Lundbeck
- LY - Eli Lilly
M to S
- MCN - McNeil Laboratories, now part of Johnson & Johnson
- MDCO - The Medicines Company
- MDL - Merrell Dow Pharmaceuticals
- MEM - Memory Pharmaceuticals
- MGX - Victory Pharma
- MK - Merck
- MLN - Millennium Pharmaceuticals
- MT - Micromet, acquired by Amgen in 2012
- NBI - Neurocrine Biosciences [15]
- NC - Nycomed
- NC - Nippon Chemiphar
- NCX - NicOx, a French Biotech
- NG - Neurogen Corp.
- OGX - OncoGenex
- OPC - Otsuka Pharmaceutical Co.
- OSI - OSI Pharmaceuticals
- PD - Parke-Davis, now Pfizer
- PF - Pfizer
- PHA - Pharmacia, now Pfizer
- PNU - Pharmacia & Upjohn, now Pfizer
- PTI - Proteostasis Therapeutics Inc
- R - Janssen Pharmaceutica, now part of Johnson & Johnson (Janssen began as Belgian and Dutch distributor for products of Gedeon Richter)
- REGN - Regeneron[2]
- RLY - Relypsa
- RMI - Richardson-Merrell
- RO - Hoffmann-La Roche
- RU - Roussel Uclaf
- RWJ - R.W. Johnson Pharmaceutical Research, now part of Johnson & Johnson
- SAGE - Sage Therapeutics
- SAN - Sandoz Pharmaceuticals, now Novartis
- SB - SmithKline Beecham, now GlaxoSmithKline
- SCH - Schering Corp., later Schering-Plough
- SKF - Smith, Kline & French, later merged into GlaxoSmithKline
- SLV - Solvay
- SNS - Sunesis Pharmaceuticals [16]
- SPD - Shire Pharmaceuticals Group plc
- SPI - Spectrum Pharmaceuticals Inc.
- SU - CIBA Pharmaceutical Company (the Summit, NJ site)
- SU - SUGEN, now Pfizer
T to Z
- TAK - Takeda
- TC - Targacept Inc.
- TG - Tragara Pharmaceuticals Inc. San Diego, CA
- TH - Threshold Pharmaceuticals Inc.[17]
- TKS - Thiakis Limited, a UK biotech company (acquired by Wyeth in 2008).[18]
- TM - TransMolecular, Inc.[19]
- TMC - Tibotec Pharmaceuticals
- TNP - Takeda Neosplastic Product, from Takeda Pharmaceutical Company, Japan
- TS - Taisho Pharmaceutical Co., a Japanese Pharmaceutical Company[20]
- U – Upjohn (merged with Pharmacia 1995)
- UK - Pfizer Sandwich, UK
- VX - Vertex Pharmaceuticals
- WAY - Wyeth (Wyeth-Ayerst, acquired by Pfizer in 2009)
- WY – Wyeth (merged with Ayerst 1987)
- XL - Exelixis [3]
- XTL - XTL Biopharmaceuticals
- XU - Sandoz Pharmaceuticals, now Novartis
- ZD - Zeneca, now AstraZeneca
References
- 1 2 "ArQule clinical pipeline". Retrieved 2016-09-16.
- 1 2 "Regeneron PCSK9 Antibody REGN727". Retrieved 2012-04-17.
- 1 2 "Exelixis HSP90 inhibitor XL888". Retrieved 2016-09-16.
- 1 2 "AbbVie pipeline, using ABBV- as prefix". Retrieved 2016-09-16.
- 1 2 "AbbVie spun out of Abbott". Retrieved 2016-09-15.
- ↑ "ADL5747". Retrieved 2008-03-19.
- ↑ "Adventrx Product List". Retrieved 2007-11-18.
- ↑ "Amgen goes 6-for-6 in Phase III". Retrieved 2014-11-25.
- ↑ "Antisense Therapeutics Ltd Home Page". Retrieved 2008-02-20.
- ↑ "Edison outlook report on YM Biosciences" (PDF). Retrieved 2016-09-19.
- ↑ "Eagle Pharmacy - Pharmaceutical Compounding". Retrieved 2016-04-26.
- 1 2 Template:Title=Genentech Pipeline
- ↑ "GDC-0152". American Chemical Society. Retrieved 2016-09-29.
- ↑ "GNE-272". American Chemical Society.
- ↑ "Neurocrine Vmat2 inhibitor NBI-98854". Retrieved 2016-09-13.
- ↑ "Sunesis BTK inhibitor SNS-062". Retrieved 2016-09-15.
- ↑ "TH-302 clinical trial". Retrieved 2013-07-23.
- ↑ "MM&M News". Retrieved 2009-02-16.
- ↑ "TransMolecular Product Pipeline". Archived from the original on 2007-07-29. Retrieved 2007-11-18.
- ↑ "Taisho Press Release". Retrieved 2008-01-07.
This article is issued from Wikipedia - version of the 11/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.